11 reports

Report Title Published Date ## NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET By Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021 h

  • Peripheral Vascular Device
  • Boston Scientific Corporation
  • Cordis Corporation
  • Covidien plc
  • Medtronic, Inc.

pathology testing market for 2017-2021 (base year: 2016 end year: 2021).

  • Cardiology
  • Peripheral Vascular Device
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Medtronic, Inc.

" Following a legacy of " firsts" for this device family, we are now the first to advance this therapy into the pivotal phase, allowing the treatment of challenging aortic arch pathologies with an off-the-shelf endovascular device. "

  • Peripheral Vascular Device
  • United States
  • Company
  • Demand
  • GlobalData's company

The business also continues to focus on developing products and solutions in pathology and infection control following the EndoChoice acquisition.

  • Cardiology
  • Clinical Trial
  • Drug Discovery And Development
  • Peripheral Vascular Device
  • GlobalData's company

Closed the acquisition of EndoChoice, enabling Boston Scientific to offer its infection control products, pathology services and single-use devices to specialists treating a wide range of gastrointestinal (GI) conditions.

  • Peripheral Vascular Device
  • United States
  • Company
  • Company Financials
  • GlobalData's company

THE BUSINESS ALSO CONTINUES TO FOCUS ON DEVELOPING PRODUCTS AND SOLUTIONS IN PATHOLOGY AND INFECTION CONTROL FOLLOWING THE ENDOCHOICE ACQUISITION.

  • Clinical Trial
  • Drug Discovery And Development
  • Peripheral Vascular Device
  • United States
  • GlobalData's company

Ferrara served as Chief Information Officer and SVP of Aurora Diagnostics' Anatomic Pathology Services Company.

  • Peripheral Vascular Device
  • North America
  • Forecast
  • Market Size
  • Medtronic, Inc.

PAUL WARING MD, PHD, IS THE CHAIR OF PATHOLOGY AND DIRECTOR OF THE CENTRE FOR TRANSLATIONAL PATHOLOGY AT THE UNIVERSITY OF MELBOURNE IN AUSTRALIA, AND HEAD OF MOLECULAR PATHOLOGY AT MELBOURNE HEALTH.

  • Peripheral Vascular Device
  • North America
  • United States
  • Forecast
  • Market Size

As we have now learned, the Fidelity ## is the only device capable of detecting the full bandwidth of pathology recommended by the American Heart Association.

  • Peripheral Vascular Device
  • Canada
  • North America
  • Forecast
  • Market Size

professor of pathology at Harvard Medical School, Mike and Sue Hazard Family MGH Research Scholar, and founder of the Tearney Lab at the Wellman Center for Photomedicine at MGH.

  • Catheter
  • Neurological Monitoring
  • Peripheral Vascular Device
  • Europe
  • Nipro Corporation

Evaluation of patients' neurological and neurocognitive functions will also be performed, as well as blinded histopathological review of the captured debris by Renu Virmani, MD, at CVPath Institute of Pathology in Gaithersburg, Maryland.

  • Cardiovascular Devices
  • Clinical Trial
  • Peripheral Vascular Device
  • United States
  • GlobalData's company